2024 - AI Applications in Predictive Toxicology Supporting Safety Assessments
Date2024-10-31
Deadline2024-10-31
VenueONLINE-VIRTUAL, USA - United States
KeywordsLife Sciences; Pharmaceutical; Drug Discovery & Development
Topics/Call fo Papers
The application of artificial intelligence (AI) technologies, such as machine learning models (e.g., QSAR) and expert rules-based systems, is a well-established practice in regulatory predictive toxicology, where they are used to support drug safety assessments.
The implementation of these methods in regulatory predictive toxicology is partly due to their adherence to principles defined in the OECD QSAR Assessment Framework (QAF) that outline criteria (based on earlier validation principles for models) to help ensure data quality, objective measures of QSAR model performance and robustness, a domain of applicability, documentation, transparency, and an underlying mechanistic interpretation where possible.
Recently, advancements in technology, such as algorithmic innovation, have led to a surge in new AI modalities. New guidelines need to be developed to ensure data reliability for models to be suitable to support regulatory assessments. In this webinar, the expert speakers will illustrate how Leadscope’s QSAR models and structural alerts adhere to the QAF and support regulatory safety assessments. They will identify current and emerging regulatory guidelines and demonstrate the applicability of structure-based predictive models.
Read more...
Register for this webinar today to explore the application of advanced AI technologies such as QSAR models and expert rules-based systems in supporting drug safety assessments.
Keywords: ADME, Drug Development, Drug Discovery, Pharmacovigilance, Regulatory, Translational Research, Toxicology/Safety, Extractables & Leachables
The implementation of these methods in regulatory predictive toxicology is partly due to their adherence to principles defined in the OECD QSAR Assessment Framework (QAF) that outline criteria (based on earlier validation principles for models) to help ensure data quality, objective measures of QSAR model performance and robustness, a domain of applicability, documentation, transparency, and an underlying mechanistic interpretation where possible.
Recently, advancements in technology, such as algorithmic innovation, have led to a surge in new AI modalities. New guidelines need to be developed to ensure data reliability for models to be suitable to support regulatory assessments. In this webinar, the expert speakers will illustrate how Leadscope’s QSAR models and structural alerts adhere to the QAF and support regulatory safety assessments. They will identify current and emerging regulatory guidelines and demonstrate the applicability of structure-based predictive models.
Read more...
Register for this webinar today to explore the application of advanced AI technologies such as QSAR models and expert rules-based systems in supporting drug safety assessments.
Keywords: ADME, Drug Development, Drug Discovery, Pharmacovigilance, Regulatory, Translational Research, Toxicology/Safety, Extractables & Leachables
Other CFPs
- Advancing Antibody-Drug Conjugate Therapies: Key Preclinical and Regulatory Strategies for Clinical Success
- The Data Leader’s Role in Measuring and Communicating the Value of Real-world Data
- Unlocking CRISPR: Advances in Base Editing, Prime Editing and Future Applications
- Accelerating Psychiatry Clinical Trials Through a Patient-Centric Approach: Real Patients, Real Outcomes
- Empowering Scientific Breakthroughs: How Scientists Can Use AI and ML for Drug Discovery
Last modified: 2024-09-17 05:20:20